[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertise Here
October 22, 2010

Microarrays Move Closer To The Clinic

Medical Diagnostics: New microarray scanning technology could allow doctors to quickly diagnose disease in the office or the field

Laura Cassiday

BENCH TO BEDSIDE Doctors could use microarrays developed at the University of Utah to diagnose disease Shutterstock
BENCH TO BEDSIDE Doctors could use microarrays developed at the University of Utah to diagnose disease.
  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

Because microarrays can simultaneously detect multiple molecules from a person's body, they hold great promise for individualized diagnosis and treatment of disease. Yet so far, the lab-on-a-chip has struggled to move out of the lab. Now researchers have developed a new microarray platform that offers fast, cheap, and portable sensing capabilities, opening the door for use in the clinic and field (Anal. Chem., DOI: 10.1021/ac101571b).

The U.S. Food and Drug Administration has approved only a handful of microarray tests for clinical diagnosis. These tests, which cost thousands of dollars, require doctors to send samples to remote laboratories for analysis. This makes them impractical for time-sensitive situations such as suspected heart attacks or bioterrorist strikes, says James Herron, a pharmaceutical chemist at the University of Utah.

So Herron and his colleagues developed a new way to read microarray results called in-plane parallel scanning (IPPS). IPPS uses a grid of channels, called waveguides, embedded within the microarray chip. The waveguides direct light to and from spots on the surface of the chip where assays for proteins reside. By measuring the intensity of light exiting from the waveguides, researchers can determine whether or not a specific molecule is present in a sample. In other microarray setups, an expensive laser must scan the entire array, one spot at a time. With IPPS, the gridded microarrays allow scientists to scan only the exits to the waveguides to collect data on multiple spots at once.

Herron's team tested the ability of IPPS to detect two proteins commonly associated with infections acquired in hospitals. Using a standard fluorescent assay, they successfully detected sub-picomolar levels of interleukin-1β, a human protein involved in immune response and inflammation, and Clostridium difficile toxin A, a harmful bacterial protein.

IPPS is not only sensitive, but also fast. "Because we can monitor molecular interactions in real time, in most cases we get enough data to reach a conclusion within 5 minutes," says Herron. In contrast, with existing systems researchers must wait 12 to 24 hours before scanning. The IPPS platform is also much less expensive than laser scanning: about $1000, according to Herron, compared with at least $100,000 for a confocal laser scanner.

The researchers hope to improve the sensitivity and make the microarray system even smaller than its current 6 x 3 x 3 inches. In addition, Herron's team is developing medically important assays such as one for the early detection of acute myocardial infarction.

Richard Thompson, a biochemist at the University of Maryland School of Medicine, admires Herron's ingenuity, calling IPPS a "clever, credible way" to quickly detect multiple proteins in samples outside of the lab. He adds: "For sure it's a better mousetrap."

GUIDING LIGHT Two sets of channels (shown in red and blue) direct light to and from sample wells to detect biomolecules. Anal. Chem.
GUIDING LIGHT Two sets of channels (shown in red and blue) direct light to and from sample wells to detect biomolecules.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!